businesspress24.com - Vedant Automates Blood Bank System Validations
 

Vedant Automates Blood Bank System Validations

ID: 1046608

Integrated System Speeds Traditional Manual Process, Delivers Immediate ROI

(firmenpresse) - NEWBURYPORT, MA -- (Marketwire) -- 10/17/11 -- , the leading provider of integrated testing, risk management, and quality governance solutions for healthcare information systems, today released a requirements-based validation service to ensure healthcare organizations meet stringent blood blank specifications. Vedant has integrated the validation service with ®, its automated testing solution in use by thousands of healthcare providers, to automate and eliminate the limitations of the traditional manual process, and provide documentation linked to the requirements mandated by regulatory organizations such as AABB, CAP, FDA and ISBT.

"While blood bank transfusion and donor systems continue to improve in capability, the ability to monitor and document the safety of these systems has not kept pace, increasing the risk of errors and patient injury. New functionalities, including multiple-facility differentiating logic and flexible order catalogs, are rarely overseen through traditional, manual validation practices using testing scripts," said Scott Almeda, CEO of Vedant. "Our TestStream-based validation technology is a comprehensive approach to these issues, and can deliver substantial ROI on its first deployment and application."

"Vedant's automated approach is long overdue, protecting the best interests of hospitals and patients alike, and is unrivaled in its capability. Not only does this integrated TestStream system automate the manual process that can take months, it can typically complete the task in one month, delivering fast ROI, and freeing IT staff and blood bank validation IT consultants to work on other projects," said Janelle Joseph, MT (ASPC) at Vedant. Joseph has years of experience in blood bank systems, having worked for system vendors, and overseen many instances of implementation.

TestStream Speeds Complete System Validation

TestStream automates the extraction of all system data and settings for patient/unit compatibility and interpretations. With this requirements-based validation, documentation is provided that links the validation steps to specific requirements. In addition, all system functions -- from patient admission, orders, test and results to blood product entry, testing, allocation and issue -- can be tested, using scenarios customized according to clients' specific procedures and workflows. Furthermore, these scenarios can be readily re-used to test future patches and upgrades. Validation results are fully documented with screenshots of all steps and pass/fail reports, and a defect tracking system that helps clients prioritize and manage issues for remediation.





TestStream automation easily integrates across best-of-breed IT environments, giving laboratory, IT and risk management staff critical, continuous assurance of the quality and stability of their healthcare information system, regardless of interfaces and modification scale or frequency. This can drastically cut the time to complete system validation from two to four months to four to six weeks.

Vedant Incorporated, founded in 1989, is a privately-held, U.S.-based corporation headquartered in Newburyport, Massachusetts. Vedant's business focus is the continued innovation of unparalleled quality-governance solutions for today's heterogeneous IT environments, with a specific emphasis on automated quality-lifecycle management of acute healthcare systems. Vedant provides its customers thorough, exceedingly reliable, and easy-to-use testing solutions. These solutions provide superior levels of quality governance of business-critical applications, mitigate the risk of system changes, and contribute significant ROI to organizations by reducing risk, maximizing IT investments, and optimizing testing methodologies and results to provide the highest levels of patient safety. .





Larry Bouchie
TurboPR

781-620-0278


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Proteonomix, Inc. (PROT) Examines Licensing of Diabetes Stem Cell Technology
Justin Shrader, Advocate for Mesothelioma Victims, to Co-Chair
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 17.10.2011 - 10:00 Uhr
Sprache: Deutsch
News-ID 1046608
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEWBURYPORT, MA


Phone:

Kategorie:

Hospitals, Facilities and Providers


Anmerkungen:


Diese Pressemitteilung wurde bisher 94 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Vedant Automates Blood Bank System Validations
"
steht unter der journalistisch-redaktionellen Verantwortung von

Vedant (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Vedant



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 137


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.